JP2008537958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008537958A5 JP2008537958A5 JP2008506722A JP2008506722A JP2008537958A5 JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5 JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- wisp
- domain
- cancer cells
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/105,876 US7455834B2 (en) | 2002-06-29 | 2005-04-14 | Methods and compositions for modulating and detecting WISP activity |
| US11/105,876 | 2005-04-14 | ||
| PCT/US2006/014008 WO2006113402A1 (en) | 2005-04-14 | 2006-04-13 | Methods and compositions for modulating and detecting wisp activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008537958A JP2008537958A (ja) | 2008-10-02 |
| JP2008537958A5 true JP2008537958A5 (enExample) | 2009-05-28 |
| JP4979684B2 JP4979684B2 (ja) | 2012-07-18 |
Family
ID=36809580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008506722A Active JP4979684B2 (ja) | 2005-04-14 | 2006-04-13 | Ｗｉｓｐ活性を調節し検出するための方法及び組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7455834B2 (enExample) |
| EP (1) | EP1869086B1 (enExample) |
| JP (1) | JP4979684B2 (enExample) |
| KR (1) | KR101320261B1 (enExample) |
| CN (1) | CN101198623B (enExample) |
| AU (1) | AU2006236649B2 (enExample) |
| BR (1) | BRPI0612184A8 (enExample) |
| CA (1) | CA2604933C (enExample) |
| ES (1) | ES2388993T3 (enExample) |
| IL (1) | IL186095A (enExample) |
| MX (1) | MX2007012798A (enExample) |
| NO (1) | NO20075825L (enExample) |
| NZ (1) | NZ561709A (enExample) |
| RU (1) | RU2412201C2 (enExample) |
| WO (1) | WO2006113402A1 (enExample) |
| ZA (1) | ZA200708738B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| BR112014019741A2 (pt) | 2012-02-11 | 2020-12-22 | Genentech, Inc | Usos de um antagonista da via wnt, uso de uma terapia anticâncer, método de identificação de um indivíduo com câncer, métodos para prever, método de inibição da proliferação de uma célula de câncer, uso de um antagonista da translocação de r-spondina e antagonista da translocação de r-spondina isolado |
| US20160279269A1 (en) * | 2013-03-27 | 2016-09-29 | Ge Healthcare As | Method and reagent for preparing a diagnostic composition |
| US10272154B2 (en) | 2014-04-15 | 2019-04-30 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind WISP1 |
| KR102011366B1 (ko) * | 2016-11-17 | 2019-10-14 | 연세대학교 산학협력단 | 암 전이 억제제의 스크리닝 방법 |
| CN112118857A (zh) * | 2018-05-17 | 2020-12-22 | 株式会社橄榄生物科技 | 用于预防或治疗视网膜疾病的包含ccn5作为活性成分的药物组合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| WO1999021998A1 (en) | 1997-10-29 | 1999-05-06 | Genentech, Inc. | Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| CA2479498A1 (en) | 1999-03-08 | 2001-07-26 | Genentech, Inc. | Compositions and methods for the treatment of tumor |
| DE60333669D1 (de) | 2002-06-29 | 2010-09-16 | Genentech Inc | Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität |
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| WO2005025603A2 (en) | 2003-09-11 | 2005-03-24 | Genentech, Inc. | Methods of using wisp antagonists |
-
2005
- 2005-04-14 US US11/105,876 patent/US7455834B2/en not_active Expired - Lifetime
-
2006
- 2006-04-13 NZ NZ561709A patent/NZ561709A/en not_active IP Right Cessation
- 2006-04-13 WO PCT/US2006/014008 patent/WO2006113402A1/en not_active Ceased
- 2006-04-13 RU RU2007142005/10A patent/RU2412201C2/ru not_active IP Right Cessation
- 2006-04-13 EP EP06750127A patent/EP1869086B1/en active Active
- 2006-04-13 KR KR1020077023542A patent/KR101320261B1/ko not_active Expired - Fee Related
- 2006-04-13 MX MX2007012798A patent/MX2007012798A/es active IP Right Grant
- 2006-04-13 BR BRPI0612184A patent/BRPI0612184A8/pt active Search and Examination
- 2006-04-13 AU AU2006236649A patent/AU2006236649B2/en not_active Ceased
- 2006-04-13 JP JP2008506722A patent/JP4979684B2/ja active Active
- 2006-04-13 CA CA2604933A patent/CA2604933C/en not_active Expired - Fee Related
- 2006-04-13 ES ES06750127T patent/ES2388993T3/es active Active
- 2006-04-13 CN CN2006800215473A patent/CN101198623B/zh active Active
- 2006-04-13 ZA ZA200708738A patent/ZA200708738B/xx unknown
-
2007
- 2007-09-20 IL IL186095A patent/IL186095A/en not_active IP Right Cessation
- 2007-11-13 NO NO20075825A patent/NO20075825L/no not_active Application Discontinuation
-
2008
- 2008-10-20 US US12/254,649 patent/US7732567B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20150432T1 (hr) | Indentifikacija antigena povezanih s tumorom za dijagnozu i terapiju | |
| RU2012137503A (ru) | Лекарственный препарат для лечения и/или профилактики рака | |
| HRP20240495T1 (hr) | Anti-garp antitijelo | |
| CY1117031T1 (el) | Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου | |
| RU2013155455A (ru) | Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6 | |
| RU2007136026A (ru) | Варианты ил-21 | |
| MX2020008613A (es) | Conjugados de anticuerpo anti-factor tisular-farmaco y su uso en el tratamiento de cancer. | |
| NZ704295A (en) | Compositions and methods for the treatment of infections and tumors | |
| RU2012140185A (ru) | Ингибирование ангиогенеза | |
| RU2017138468A (ru) | Антитела против человеческого her3, имеющие низкое содержание фукозы, и области их применения | |
| HK1255815A1 (zh) | 治療腹膜癌的組合物和方法 | |
| WO2015200828A8 (en) | Conjugates for immunotherapy | |
| Choi et al. | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB–IV non-small cell lung cancer unsuitable for radical therapy: Korean results | |
| JP2015506961A5 (enExample) | ||
| RU2014134923A (ru) | Антагонисты alk1 и их применение в лечении почечно-клеточного рака | |
| MX2022005704A (es) | Peptidos antigenicos para la prevencion y el tratamiento de malignidad de celulas b. | |
| GEAP202416383A (en) | Use of medicament in treatment of tumor disease | |
| HRP20231636T1 (hr) | Igg epitop i njegova primjena kao cilja | |
| MX2019009121A (es) | Antcuerpos anti-kaag1 o fragmento de union al antigeno del mismo para el tratamiento de cancer de mama triple negativo. | |
| JP2008537958A5 (enExample) | ||
| GB2474807A (en) | Vhz for diagnosis and treatment of cancers | |
| ME02725B (me) | Inhibitori proteazoma za lećenje kancera | |
| BRPI0707247B8 (pt) | vacina para tumor compreendendo células tumorais alogênicas ou xenogênicas | |
| ES2348161T3 (es) | Métodos para dañar células usando funciones efectoras de anticuerpos anti-gfra1. | |
| Hana et al. | Molecular Targeting of the Claudins Pathway. |